IBOV 166,934.20 ▼ 0.10% IPSA 11,042.67 ▲ 0.39% IPC MEX 64,397.45 ▼ 0.66% MERVAL 2,947,349 ▼ 1.77% COLCAP 2,452.46 ▲ 0.84% BVL PERÚ 58,104.31 ▲ 0.40% USD/BRL5.21▼ 0.01% USD/MXN17.02▼ 0.01% USD/CLP914.45▼ 0.02% USD/COP3,141▲ 0.56% USD/PEN3.37▼ 0.01% USD/ARS1,488— 0.00% USD/UYU40.33▲ 1.98% USD/PYG5,984▲ 2.11% USD/BOB11.54▼ 0.18% USD/DOP58.45▲ 0.55% USD/CRC446.12▲ 0.91% USD/GTQ7.62▲ 2.25% USD/HNL26.79▲ 1.50% USD/NIO36.62▲ 0.63% USD/VES769.14▼ 0.32% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.70▲ 0.74% EUR/BRL6.05▲ 1.03% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 166,934.20 ▼ 0.10% IPSA 11,042.67 ▲ 0.39% IPC MEX 64,397.45 ▼ 0.66% MERVAL 2,947,349 ▼ 1.77% COLCAP 2,452.46 ▲ 0.84% BVL PERÚ 58,104.31 ▲ 0.40% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Sunday, August 16, 2026

Covid-19 Brazil

Covid-19 vaccine rejection grows in 2,097 Brazilian municipalities – CNM survey

By · July 16, 2021 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The 17th edition of the National Confederation of Municipalities (CNM) survey on the Covid-19 pandemic detected people seeking to choose vaccines. According to the survey, 2,109 (74.6%) cities reported this type of position. Another 687 (24.3%) did not report this position among their citizens.

Cases of people refusing to be administered certain immunizers were also reported. The most widely refused vaccines were the CoronaVac – 1,067 (50.6%), Oxford/AstraZeneca, 829 (39.3%) and, to a lesser extent, Janssen, 66 (3.1%).

In 689 municipalities, mayors did not report rejection to vaccines. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Supply

Among the cities that took part in the survey, 2,025 (71.7%) said they had no Covid-19 vaccine shortage issues this week. The number of cities that experienced supply shortages reached 775 (27.4%), higher than last week’s record, when 17.7% of cities reported such issues.

Among the cities that were not supplied with immunizers, 739 (95.4%) lacked the first dose. In 102 (13.2%) of cities without vaccines, the second dose was lacking.

Age group

Among the cities heard, 74.6% started immunization in age groups under 60. According to the survey, 132 (4.7%) are in the 50 to 55 age group, 349 (12.4%) from 45 to 49, 709 (25.2%) from 40 to 44, 1,070 (38%) from 35 to 39, 379 (13.5%) from 30 to 34, 84 (3%) from 25 to 29, and 69 (2.4%) in the 18 to 24 age group.

Of the total number of municipal administrations surveyed, 1,975 (69.9%) reported the adoption of some form of distancing or restriction in the hours of non-essential activities. Another 808 (28.6%) answered that they had not implemented any such measure during the pandemic. Last week, distancing rules were reported by 72.4% of the cities surveyed.

Cases and deaths

Among the municipalities surveyed, in 1,142 (40.4%) there was a decline in the number of Covid-19 cases, in 143 (5.1%) no new cases were reported, in 1,036 (36.7%) cases remained stable, and in 469 (16.6%) there was an increase.

As for deaths, in 1,426 (50.5%) no new deaths were reported, in 610 (21.6%) the situation remained stable, in 465 (16.5%) there was a decrease, and in 289 (10.2%), an increase in the number of lives lost was reported.

Supplies

The risk of “intubation kit” medicine shortage was reported by 218 cities, representing 7.7% of the total. Other 2,326 did not report the issue, equivalent to 82.3%.

Last week, the proportion of cities reporting the issue stood at 9.8%. The “intubation kit” comprises medicines used for ventilation support in Covid-19 patients, such as anesthetics and neuroblockers.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.